{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:11:30Z","timestamp":1788923490023,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"NASKHO (National Antilles Foundation for Clinical Higher Education)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Negat Results BioMed"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12952-017-0079-y","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T12:28:20Z","timestamp":1503664100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII"],"prefix":"10.1186","volume":"16","author":[{"given":"Charlotte L.","family":"Mentzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Roberto","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"van Os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Drukker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Matroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A. J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"van Harten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"issue":"2","key":"79_CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0920-9964(95)00096-8","volume":"19","author":"P Harten Van","year":"1996","unstructured":"Van Harten P, Matroos G, Hoek H, Kahn R. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia the Curacao Extrapyramidal syndromes study: I. Schizophr Res. Elsevier. 1996;19(2):195\u2013203.","journal-title":"Schizophr Res"},{"key":"79_CR2","unstructured":"Bakker P, de Groot I, van Os J, van Harten P. Predicting the incidence of antipsychotic-induced movement disorders in long-stay patients: a prospective study. Epidemiology and psychiatric sciences. Cambridge Univ Press; 2013;22(04):375\u20139."},{"issue":"9","key":"79_CR3","first-page":"593","volume":"87","author":"L Zaghdoudi","year":"2009","unstructured":"Zaghdoudi L, Homri W, Belaid S, Ben BM, Labbane R. Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics. La Tunisie Medicale. 2009;87(9):593\u20138.","journal-title":"La Tunisie Medicale"},{"issue":"Suppl 2","key":"79_CR4","first-page":"14","volume":"6","author":"BL Saltz","year":"2004","unstructured":"Saltz BL, Robinson DG, Woerner MG. Recognizing and managing antipsychotic drug treatment side effects in the elderly. Prim Care Companion J Clin Psychiatry. Citeseer. 2004;6(Suppl 2):14\u20139.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"s382","key":"79_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1994.tb05859.x","volume":"89","author":"WWMUGVKM Fleischhacker","year":"1994","unstructured":"Fleischhacker WWMUGVKM. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand. Wiley Online Library. 1994;89(s382):11\u20135.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"79_CR6","first-page":"298","volume":"24","author":"CE Dean","year":"2004","unstructured":"Dean CE, Russell JM, Kuskowski MA, Caligiuri MP, Nugent SM. Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? Journal of clinical psychopharmacology. LWW. 2004;24(3):298\u2013304.","journal-title":"LWW"},{"issue":"2","key":"79_CR7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/schbul\/16.2.345","volume":"16","author":"CN Karson","year":"1990","unstructured":"Karson CN, Dykman RA, Paige SR. Blink rates in schizophrenia. Schizophrenia bulletin. National Institute of Mental Health. 1990;16(2):345.","journal-title":"Schizophrenia bulletin"},{"issue":"4","key":"79_CR8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00415-011-6261-0","volume":"259","author":"E Fitzpatrick","year":"2012","unstructured":"Fitzpatrick E, Hohl N, Silburn P, O\u2019Gorman C, Broadley SA. Case\u2013control study of blink rate in Parkinson\u2019s disease under different conditions. J Neurol Springer. 2012;259(4):739\u201344.","journal-title":"J Neurol Springer"},{"issue":"1","key":"79_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0269881104042832","volume":"18","author":"J Post Van der","year":"2004","unstructured":"Van der Post J, De Waal P, De Kam M, Cohen A, van Gerven J. No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity. J Psychopharmacol. Sage Publications. 2004;18(1):109\u201314.","journal-title":"J Psychopharmacol"},{"issue":"11","key":"79_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.nmd.0000144697.48042.eb","volume":"192","author":"RC Chan","year":"2004","unstructured":"Chan RC, Chen EY. Blink rate does matter: a study of blink rate, sustained attention, and neurological signs in schizophrenia. J Nerv Mental Disease. LWW. 2004;192(11):781\u20133.","journal-title":"J Nerv Mental Disease"},{"issue":"7","key":"79_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0006-3223(95)00482-3","volume":"40","author":"EY Chen","year":"1996","unstructured":"Chen EY, Lam LC, Chen RY, Nguyen DG. Blink rate, neurocognitive impairments, and symptoms in schizophrenia. Biol Psychiatry. Elsevier. 1996;40(7):597\u2013603.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"79_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0920-9964(91)90008-F","volume":"4","author":"A Mackert","year":"1991","unstructured":"Mackert A, Flechtner K-M, Woyth C, Frick K. Increased blink rates in schizophrenics: influences of neuroleptics and psychopathology. Schizophr Res. Elsevier. 1991;4(1):41\u20137.","journal-title":"Schizophr Res"},{"issue":"1","key":"79_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mds.870090112","volume":"9","author":"P Martinez-Martin","year":"1994","unstructured":"Martinez-Martin P, Gil-Nagel A, Gracia LM, G\u00f3mez JB, Martinez-Sarri\u00e9s J, Bermejo F. Unified Parkinson\u2019s disease rating scale characteristics and structure. Mov Disord. Wiley Online Library. 1994;9(1):76\u201383.","journal-title":"Mov Disord"},{"key":"79_CR14","volume-title":"Stata statistical software: release 12","author":"StataCorp","year":"2011","unstructured":"StataCorp. Stata statistical software: release 12. College Station: StataCorp LP; 2011."},{"key":"79_CR15","unstructured":"WHO, Collaborating Centre for Drugs Statistics Methodology [Internet]. [cited 2013 Jun]. Available from: http:\/\/www.whocc.no\/atcddd\/"},{"issue":"11","key":"79_CR16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0006-3223(90)90417-Z","volume":"27","author":"A Mackert","year":"1990","unstructured":"Mackert A, Woyth C, Flechtner K-M, Volz H-P. Increased blink rate in drug-naive acute schizophrenic patients. Biol Psychiatry. Elsevier. 1990;27(11):1197\u2013202.","journal-title":"Biol Psychiatry"},{"key":"79_CR17","doi-asserted-by":"crossref","unstructured":"Bakker PR, de Groot IW, van Os J, van Harten PN. Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder. PLoS One. Public Library of Science. 2011;6(10) e25588","DOI":"10.1371\/journal.pone.0025588"},{"key":"79_CR18","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd; 1992;55(3):181\u20134."},{"issue":"1","key":"79_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","volume":"8","author":"H-W Shin","year":"2012","unstructured":"Shin H-W, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8(1):15\u201321.","journal-title":"J Clin Neurol"},{"issue":"2","key":"79_CR20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-3223(91)90042-K","volume":"29","author":"MP Caligiuri","year":"1991","unstructured":"Caligiuri MP, Lohr JB, Sefan Bracha H, Jeste DV. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia. Biol Psychiatry. Elsevier. 1991;29(2):139\u201348.","journal-title":"Biol Psychiatry"},{"key":"79_CR21","unstructured":"Mentzel TQ, Lieverse R, Levens A, Mentzel CL, Tenback DE, Bakker PR, et al. Reliability and validity of an instrument for the assessment of bradykinesia. Psychiatry Res. Elsevier. 2016;238:189\u201395."},{"issue":"3","key":"79_CR22","first-page":"271","volume":"88","author":"A Annamalai","year":"2015","unstructured":"Annamalai A, Singh N, O\u2019Malley SS. Focus: addiction: smoking use and cessation among people with serious mental illness. Yale J Biol Med. 2015;88(3):271.","journal-title":"Yale J Biol Med"}],"container-title":["Journal of Negative Results in BioMedicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12952-017-0079-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T12:28:44Z","timestamp":1503664124000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnrbm.biomedcentral.com\/articles\/10.1186\/s12952-017-0079-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1186\/s12952-017-0079-y","relation":{},"ISSN":["1477-5751"],"issn-type":[{"value":"1477-5751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]},"article-number":"15"}}